The guidelines are effective from Jan. 1, 2021 through Sept. 30, 2021.

On Dec. 16, 2020, the Centers for Disease Control and Prevention (CDC) released updated ICD-10-CM Official Coding and Reporting Guidelines for 2021. The updated document can be found on the CDC website. The changes are focused on COVID-19 (Chapters 1, 15, and 16) and Vaping-Related Disorder (Chapter 10). The guidelines are effective from Jan. 1,2021 through Sept. 30, 2021.

In Chapter 1 (Infectious and Parasitic Diseases), the guidance states that only confirmed COVID-19 cases should be assigned U07.1. The documentation to support the diagnosis is created by the provider. A positive test result is not required. If COVID-19 is possible, probable, or likely, assign codes for the presenting symptoms.

The code sequencing related to COVID should be assigned as the principal diagnosis when the patient’s presentation meets the definition. If another coding guideline or instruction requires different sequencing, then the coder should follow the instruction. If the reason for the encounter is respiratory manifestations, assign U07.1 as the principal diagnosis. Here are some examples:

  • Pneumonia – U07.1 and J12.82
  • Acute bronchitis – U07.1 and J20.8
  • Bronchitis NOS – U07.1 and J40
  • Acute lower respiratory infection – U07.1 and J22
  • Lower respiratory infection – U07.1 and J98.8
  • Acute respiratory distress syndrome – U07.1 and J80
  • Acute respiratory failure – U07.1 and J96.0-

If the patient has non-respiratory manifestations of COVID, then assign U07.1, with codes for those manifestations.

If the patient has had exposure to COVID-19 and is asymptomatic, then assign Z20.822. If the patient is symptomatic, but infection has been ruled out, the same code is assigned. For patients who are screened during the pandemic, it is not appropriate to assign Z11.52 (Screening for COVID-19). The guidelines state that the exposure code for testing should be assigned, Z20.822. The code would be assigned for pre-operative testing. If the patient has signs and symptoms and is without a definitive diagnosis, then assign codes for the presenting signs and symptoms. If the patient has had contact with a suspected or actual COVID case, assign the exposure code. If the patient is asymptomatic and has a positive test, then assign U07.1, as the patient is considered to have COVID-19.

If the patient has a personal history of COVID-19, then assign Z86.16. If the patient presents for a follow-up visit after COVID-19 has resolved, then assign Z09 (encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm) and Z86.16 (Personal history of COVID-19). If the patient presents for antibody testing, then assign Z01.84.

For patients who have been diagnosed with multisystem inflammatory syndrome (MIS), assign U07.1 and M35.81. If MIS develops after the COVID infection, then assign M35.81 and B94.8. If MIS develops with a history of COVID-19 and there is no relationship between the two conditions, then assign M35.81 and Z86.16. If MIS develops after an exposure to COVID-19, then assign M35.81 and Z20.822.

The sequencing is impacted for pregnancies and newborns. For COVID-19 diagnosed during pregnancy, assign O98.5- and U07.1. If the encounter is unrelated to COVID-19, but the patient tests positive during the encounter, assign O98.5- and U07.1 as secondary diagnoses. For newborns diagnosed with COVID-19, the Z38 category code would be assigned as the principal diagnosis and U07.1 would be a secondary diagnosis.  If COVID-19 is documented as contracted in-utero or during the birth process, then assign P35.8 and U07.1.

Another topic that was included in the guideline update was vaping-related disorder. For conditions related to vaping, assign U07.0. Assign codes for additional manifestations, such as acute respiratory failure. Codes for associated respiratory signs and symptoms due to vaping are not separately assigned when a definitive diagnosis has been established. It would be appropriate to code for signs and symptoms of other body systems, such as gastrointestinal.

This guideline update provides needed insight to the new ICD-10-CM codes for COVID-19 and vaping. Happy New Year!

Programming Note: Listen to Laurie Johnson report this story live today during Talk Ten Tuesdays at 10 a.m. Eastern.

 

Facebook
Twitter
LinkedIn

Laurie M. Johnson, MS, RHIA, FAHIMA, AHIMA Approved ICD-10-CM/PCS Trainer

Laurie Johnson is currently a senior healthcare consultant for Revenue Cycle Solutions, based in Pittsburgh, Pa. Laurie is an AHIMA-approved ICD-10-CM/PCS trainer. She has more than 35 years of experience in health information management and specializes in coding and related functions. She has been a featured speaker in over 40 conferences. Laurie is a member of the ICD10monitor editorial board and is a permanent panelist on Talk Ten Tuesdays

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Mastering Principal Diagnosis: Coding Precision, Medical Necessity, and Quality Impact

Mastering Principal Diagnosis: Coding Precision, Medical Necessity, and Quality Impact

Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.

December 3, 2025

Proactive Denial Management: Data-Driven Strategies to Prevent Revenue Loss

Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.

November 25, 2025
Sepsis: Bridging the Clinical Documentation and Coding Gap to Reduce Denials

Sepsis: Bridging the Clinical Documentation and Coding Gap to Reduce Denials

Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.

September 24, 2025

Trending News

Featured Webcasts

AI in Claims Auditing: Turning Compliance Risks into Defensible Systems

As AI reshapes healthcare compliance, the risk of biased outputs and opaque decision-making grows. This webcast, led by Frank Cohen, delivers a practical Four-Pillar Governance Framework—Transparency, Accountability, Fairness, and Explainability—to help you govern AI-driven claim auditing with confidence. Learn how to identify and mitigate bias, implement robust human oversight, and document defensible AI review processes that regulators and auditors will accept. Discover concrete remedies, from rotation protocols to uncertainty scoring, and actionable steps to evaluate vendors before contracts are signed. In a regulatory landscape that moves faster than ever, gain the tools to stay compliant, defend your processes, and reduce liability while maintaining operational effectiveness.

January 13, 2026
Surviving Federal Audits for Inpatient Rehab Facility Services

Surviving Federal Audits for Inpatient Rehab Facility Services

Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.

November 13, 2025
E/M Services Under Intensive Federal Scrutiny: Navigating Split/Shared, Incident-to & Critical Care Compliance in 2025-2026

E/M Services Under Intensive Federal Scrutiny: Navigating Split/Shared, Incident-to & Critical Care Compliance in 2025-2026

During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.

August 26, 2025

Trending News

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24